Update on Omicron
On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that Omicron has several mutations that may have an impact on how it behaves, for example, on how easily it spreads or the severity of illness it causes. Here is a
-sars-cov-2-variant-of-concern)
Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern
The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) is an independent group of experts that periodically monitors and evaluates the evolution of SARS-CoV-2 and assesses if specific mutations and combinations of mutations alter the behaviour of the virus. The TAG-VE was convened on 26 November 2021 to assess the SARS-CoV-2 variant: B.1.1.529. The B.1.1.529 variant was first reported
Therapeutics and COVID-19: living guideline
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, and is updated regularly as new evidence emerges. This tenth version of the WHO living guideline now co
WHO Director-General's keynote speech at the 138th International Olympic Committee Session
Home/ WHO Director-General/ Speeches/ Detail/ WHO Director-General's keynote speech at the 138th International Olympic Committee Session I have come this time – to this global mountaintop – with a message for the world’s people to hear. Our focus as a world united must be on doing everything we can to triumph over the pandemic, with determination, dedication and discipline. We are not in a race ag
Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time
Home/ News/ item/ Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time In just six months, the world’s largest randomized control trial on COVID-19 therapeutics has generated conclusive evidence on
Cleaning and disinfection of environmental surfaces in the context of COVID-19
Overview The purpose of this document is to provide guidance on the cleaning and disinfection of environmental surfaces in the context of COVID-19. This guidance is intended for health care professionals, public health professionals and health authorities that are developing and implementing policies and standard operating procedures (SOP) on the cleaning and disinfection of environmental surfaces
WHO Director-General's opening remarks at the media briefing on COVID-19 - 8 June 2020
Home/ WHO Director-General/ Speeches/ Detail/ WHO Director-General's opening remarks at the media briefing on COVID-19 - 8 June 2020 Good morning, good afternoon and good evening. Yesterday marked World Food Safety Day. Food safety is everyone’s business, every day. In times of crisis, it’s more important than ever. We want to thank those who have continued to ensure that people can access safe fo
リリース、障害情報などのサービスのお知らせ
最新の人気エントリーの配信
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く
WHO Director-General's opening remarks at the media briefing on COVID-19 and Ukraine – 9 March 2022
WHO Director-General's opening remarks at the media briefing on COVID-19 - 22 December 2021
WHO Director-General's opening remarks at the media briefing on COVID-19 - 29 December 2021
WHO advice for international traffic in relation to the SARS-CoV-2 Omicron variant (B.1.1.529)
WHO Director-General's opening remarks at the media briefing on COVID-19 - 1 December 2021
WHO Director-General's opening remarks at the Member State Information Session on the Omicron variant of SARS-CoV-2
WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs
Director-General's opening remarks at the World Health Assembly - 24 May 2021
World Health Statistics 2021: A visual summary
Director-General's opening remarks at Member State Information Session on COVID-19 - 13 May 2021
WHO Director-General's opening remarks at the media briefing on COVID-19 – 5 February 2021
WHO issues new 10-year plan to end suffering from neglected tropical diseases
WHO Director-General's opening remarks at the media briefing on COVID-19 – 5 January 2021